{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:46:41Z","timestamp":1783777601038,"version":"3.55.0"},"reference-count":13,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2019,6,3]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>The new \u2018Controversies In\u2026\u2019 series for the Frontline Gastroenterology Twitter debates addressed the difficult area of functional gastrointestinal disorders, facilitated by the former editor-in-chief Anton Emmanuel. Key topics discussed included distinguishing functional dyspepsia from genuine gastroparesis, when we should investigate for bile acid malabsorption, the current treatments for constipation-predominant irritable bowel syndrome and, importantly, how to manage consultations with complex patients presenting with functional bowel disease. The debate generated over a million impressions on twitter and this article aims to summarise the key educational points from the event.<\/jats:p>","DOI":"10.1136\/flgastro-2019-101246","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T17:15:49Z","timestamp":1563556549000},"page":"249-251","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Twitter debate: controversies in functional gastrointestinal disorders"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-5328","authenticated-orcid":false,"given":"James","family":"Maurice","sequence":"first","affiliation":[{"name":"Deparment of Hepatology, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M","family":"Widlak","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton V","family":"Emmanuel","sequence":"additional","affiliation":[{"name":"Department of Physiology Unit, University College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"2025090709253545000_11.3.249.1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.078634"},{"key":"2025090709253545000_11.3.249.2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome Foundation working team report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"2025090709253545000_11.3.249.3","doi-asserted-by":"crossref","unstructured":"Ford AC . Intending to treat patients with irritable bowel syndrome with Cognitive\u2013Behavioral therapy. Gastroenterology 2018;155.doi:10.1053\/j.gastro.2018.05.054","DOI":"10.1053\/j.gastro.2018.05.054"},{"key":"2025090709253545000_11.3.249.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.148"},{"key":"2025090709253545000_11.3.249.5","doi-asserted-by":"crossref","unstructured":"Vasant DH , Whorwell PJ . Gut-focused hypnotherapy for functional gastrointestinal disorders: evidence-base, practical aspects, and the Manchester protocol. Neurogastroenterol Motil 2019:e13573.doi:10.1111\/nmo.13573","DOI":"10.1111\/nmo.13573"},{"key":"2025090709253545000_11.3.249.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.021"},{"key":"2025090709253545000_11.3.249.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309122"},{"key":"2025090709253545000_11.3.249.8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308188"},{"key":"2025090709253545000_11.3.249.9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090709253545000_11.3.249.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316434"},{"key":"2025090709253545000_11.3.249.11","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12969","article-title":"Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome","volume":"29","author":"Hustoft","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"2025090709253545000_11.3.249.12","doi-asserted-by":"publisher","DOI":"10.3945\/jn.112.159285"},{"key":"2025090709253545000_11.3.249.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2011.01162.x"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2019-101246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:25:48Z","timestamp":1757262348000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2019-101246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,4,3]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/flgastro-2019-101246"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2019-101246","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]}}}